Skopos Labs, Inc. Uro Gen Pharma Ltd. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Skopos Labs, Inc. holds 74 shares of URGN stock, worth $1,328. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74Holding current value
$1,328% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
144Shares Held
41.6MCall Options Held
91.4KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$78.3 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$68.8 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$57.6 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$41.3 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$39.4 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $408M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...